These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 3524823)

  • 1. Comparative metabolism of daunorubicin and 4-demethoxydaunorubicin in mice and rabbits.
    Broggini M; Sommacampagna B; Paolini A; Dolfini E; Donelli MG
    Cancer Treat Rep; 1986 Jun; 70(6):697-702. PubMed ID: 3524823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatobiliary metabolism and urinary excretion of 4-demethoxydaunorubicin as compared to daunorubicin in rats.
    Catapano CV; Guaitani A; Broggini M; Corada M; Bartosek I; Italia C; Donelli MG
    Anticancer Res; 1988; 8(4):725-31. PubMed ID: 3178163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity and distribution of iv and oral 4-demethoxydaunorubicin in murine experimental tumors.
    Broggini M; Italia C; Colombo T; Marmonti L; Donelli MG
    Cancer Treat Rep; 1984 May; 68(5):739-47. PubMed ID: 6586294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of daunorubicinol in the rabbit: comparison with daunorubicin.
    Maniez-Devos DM; Baurain R; Trouet A; Lesne M
    J Pharmacol; 1986; 17(1):14-20. PubMed ID: 3713197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two nonsynonymous single nucleotide polymorphisms of human carbonyl reductase 1 demonstrate reduced in vitro metabolism of daunorubicin and doxorubicin.
    Bains OS; Karkling MJ; Grigliatti TA; Reid RE; Riggs KW
    Drug Metab Dispos; 2009 May; 37(5):1107-14. PubMed ID: 19204081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldo-keto reductase 1C2 fails to metabolize doxorubicin and daunorubicin in vitro.
    Takahashi RH; Bains OS; Pfeifer TA; Grigliatti TA; Reid RE; Riggs KW
    Drug Metab Dispos; 2008 Jun; 36(6):991-4. PubMed ID: 18322072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A correlation between cytotoxicity and reductase-mediated metabolism in cell lines treated with doxorubicin and daunorubicin.
    Bains OS; Szeitz A; Lubieniecka JM; Cragg GE; Grigliatti TA; Riggs KW; Reid RE
    J Pharmacol Exp Ther; 2013 Nov; 347(2):375-87. PubMed ID: 23995598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and tissue distribution of idarubicin and its active metabolite idarubicinol in the rabbit.
    Looby M; Linke R; Weiss M
    Cancer Chemother Pharmacol; 1997; 39(6):554-6. PubMed ID: 9118470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonyl reduction of daunorubicin in rabbit liver and heart.
    Pröpper D; Maser E
    Pharmacol Toxicol; 1997 May; 80(5):240-5. PubMed ID: 9181603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of the anthracycline antibiotic daunorubicin to daunorubicinol and deoxydaunorubicinol aglycone in hepatocytes isolated from the rat and the rabbit.
    Gewirtz DA; Yanovich S
    Biochem Pharmacol; 1986 Nov; 35(22):4059-64. PubMed ID: 3778526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and cerebrospinal fluid penetration of daunorubicin, idarubicin, and their metabolites in the nonhuman primate model.
    Berg SL; Reid J; Godwin K; Murry DJ; Poplack DG; Balis FM; Ames MM
    J Pediatr Hematol Oncol; 1999; 21(1):26-30. PubMed ID: 10029808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of daunorubicin, carminomycin, idarubicin and 4-demethoxydaunorubicinol against human normal myeloid stem cells and human malignant cells in vitro.
    Dodion P; Sanders C; Rombaut W; Mattelaer MA; Rozencweig M; Stryckmans P; Kenis Y
    Eur J Cancer Clin Oncol; 1987 Dec; 23(12):1909-14. PubMed ID: 3481336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin and daunorubicin plasmatic, hepatic and renal disposition in the rabbit with or without enterohepatic circulation.
    Maniez-Devos DM; Baurain R; Lesne M; Trouet A
    J Pharmacol; 1986; 17(1):1-13. PubMed ID: 3713196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro formation of a toxic aglycone metabolite of 4-demethoxydaunorubicin in conditions that parallel the stomach.
    Cummings J; Milroy R
    Anticancer Res; 1986; 6(5):1177-9. PubMed ID: 3467647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-performance liquid chromatographic method for pharmacokinetic studies on the new anthracycline 4-demethoxydaunorubicin and its 13-dihydro derivative.
    Moro E; Bellotti V; Jannuzzo MG; Stegnjaich S; Valzelli G
    J Chromatogr; 1983 May; 274():281-7. PubMed ID: 6575974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Daunorubicin metabolism in leukemic cells isolated from patients with acute myeloid leukemia.
    Bogason A; Masquelier M; Lafolie P; Skogastierna C; Paul C; Gruber A; Vitols S
    Drug Metab Lett; 2010 Dec; 4(4):228-32. PubMed ID: 20670211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiotoxicity and comparative pharmacokinetics of six anthracyclines in the rabbit.
    Jaenke RS; Deprez-DeCampeneere D; Trouet A
    Cancer Res; 1980 Oct; 40(10):3530-6. PubMed ID: 6934026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of (7) anthracycline related compounds in an doxorubicin sensitive human small cell lung cancer line and its doxorubicin resistant descendant. Activity of doxorubicin, daunorubicin, 4-deoxyrubicin, 4-demethoxydaunorubicin, detorubicin, 4'-epidoxorubicin and mitoxantrone.
    Zijlstra JG; Meijer C; Timmer-Bosscha H; Le TK; de Vries EG; Mulder NH
    Eur J Respir Dis Suppl; 1987; 149():53-5. PubMed ID: 3034649
    [No Abstract]   [Full Text] [Related]  

  • 20. Low dose oral administration of 4-demethoxydaunorubicin (idarubicin) in advanced cancer patients. A pharmacokinetic study.
    Pannuti F; Camaggi CM; Strocchi E; Comparsi R; Angelelli B; Pacciarini MA
    Cancer Chemother Pharmacol; 1986; 16(3):295-9. PubMed ID: 3457647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.